Live feed08:08:00·23mPRReleasevia QuantisnowMAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung CancerByQuantisnow·Wall Street's wire, on your screen.MAIA· MAIA Biotechnology Inc.Health Care
